These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7293432)

  • 1. [Hormonal status of patients with ovarian cancer].
    Merabishvili NV; Murav'eva NI; Kuz'mina ZV; Bassalyk LS; Kozachenko VP
    Vestn Akad Med Nauk SSSR; 1981; (7):41-4. PubMed ID: 7293432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Steroid hormones and ovarian carcinoma].
    Slotman BJ; Rao BR
    Ned Tijdschr Geneeskd; 1989 Oct; 133(41):2017-9. PubMed ID: 2677802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone levels in granulosa tumors of the ovary].
    Jirásek JE; Zwinger A; Stroufová A; Sulcová J
    Cesk Gynekol; 1989 Jul; 54(6):446-8. PubMed ID: 2791024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiology of ovarian cancer and female sex hormones].
    Khalil MR
    Ugeskr Laeger; 2000 Nov; 162(47):6395-8. PubMed ID: 11116449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the pretherapeutic differential diagnosis of adnexal tumors].
    Kunz J; Kunz B
    Praxis (Bern 1994); 1995 Nov; 84(46):1342-8. PubMed ID: 7491464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
    Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian neoplasms and tumor markers].
    Zarcone R; Candido R; Cardone G; De Luca P; Voto RI; Bellini P
    Minerva Ginecol; 1994 Oct; 46(10):531-3. PubMed ID: 7838408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Prontera C; Facchini V; Bianchi R; Genazzani AR
    Gynecol Oncol; 1998 Jul; 70(1):111-4. PubMed ID: 9698485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer.
    Gadducci A; Marrai R; Baicchi U; Ferdeghini M; Fanucchi A; Facchini V; Genazzani AR
    Anticancer Res; 1995; 15(6B):2683-6. PubMed ID: 8669847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression.
    Huang CC; Wei IH; Chou YH; Su TP
    Psychoneuroendocrinology; 2008 Jul; 33(6):821-31. PubMed ID: 18468810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK; Caffier H
    Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New serum markers in malignant epithelial tumors of the ovary].
    Ambrosini A; Marras V; Piga MD; Ambrosini G; Fattorini F; Canetto AM; Cherchi PL
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):18-24. PubMed ID: 11526712
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoantibodies to steroid-producing ovarian cells in cancer patients].
    Bershteĭn LM; Poroshina TE; Vasil'ev DA; Orlova AV
    Vopr Onkol; 2008; 54(5):602-5. PubMed ID: 19069474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor expression in ovarian cancer.
    Agarwal R; Whang DH; Alvero AB; Visintin I; Lai Y; Segal EA; Schwartz P; Ward D; Rutherford T; Mor G
    Am J Obstet Gynecol; 2007 Apr; 196(4):348.e1-5. PubMed ID: 17403417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of sex steroid and pituitary hormones in chronic alcoholics and head and neck cancer patients as compared to normal controls].
    Remenár E; Számel I; Budai B; Gaudi I; Kásler M; Gundy S
    Magy Onkol; 2002; 46(4):329-32. PubMed ID: 12563355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of serum il-6 and CRP after chemotherapy in patients with ovarian carcinoma].
    Zakrzewska I; Poznański J
    Pol Merkur Lekarski; 2001 Sep; 11(63):210-3. PubMed ID: 11761812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary.
    Silver HK; Karim KA; Salinas FA; Swenerton KD
    Surg Gynecol Obstet; 1981 Aug; 153(2):209-13. PubMed ID: 7244990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
    Remenár E
    Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal status of patients with mastopathy].
    Bublikov ID; Kulikov EP; Varenov BM
    Vopr Onkol; 2000; 46(2):172-4. PubMed ID: 10853415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term caffeine-induced inhibition of EAC cell progression in relation to gonadal hormonal status.
    Mandal A; Batabyal SK; Poddar MK
    Indian J Exp Biol; 2007 Apr; 45(4):347-52. PubMed ID: 17477306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.